PNMA1 promotes cell growth in human pancreatic ductal adenocarcinoma

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 7, 2014, Pages 3827-3835

  Jiang, Shu Heng ^a,b   He, Ping ^b   Ma, Ming Ze ^b   Wang, Yang ^a,b   Li, Rong kun ^b   Fang, Fang ^b   Fu, Ying ^b   Tian, Guang Ang ^b   Qin, Wen Xin ^a,b   Zhang, Zhi Gang ^b  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apoptosis; Cell survival; Growth; Pancreatic ductal adenocarcinoma; PNMA1

Indexed keywords

ANTIGEN; MA1 ANTIGEN;

AGED; CELL PROLIFERATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; TUMOR CELL LINE; WESTERN BLOTTING;

AGED; ANTIGENS; BLOTTING, WESTERN; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE ARRAY ANALYSIS;

EID: 84906256229     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Kaltsas S, Syrigos KN and Saif MW. Pancreatic cancer in 2014. JOP 2014; 15: 84-86.
2. Vincent A, Herman J, Schulick R, Hruban RH and Goggins M. Pancreatic cancer. Lancet 2011; 378: 607-620.
3. Alsamarrai A, Das SL, Windsor JA and Petrov MS. Factors that affect risk for pancreatic disease in the general population: a systematic review and meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol 2014; [Epub ahead of print].
4. The Lancet Oncology. Pancreatic cancer in the spotlight. Lancet Oncol 2014; 15: 241.
5. Dalmau J, Gultekin SH, Voltz R, Hoard R, DesChamps T, Balmaceda C, Batchelor T, Gerstner E, Eichen J, Frennier J, Posner JB and Rosenfeld MR. Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain 1999; 122: 27-39.
6. Schuller M, Jenne D and Voltz R. The human PNMA family: novel neuronal proteins implicated in paraneoplastic neurological disease. J Neuroimmunol 2005; 169: 172-176.
7. Tan KO, Tan KM, Chan SL, Yee KS, Bevort M, Ang KC and Yu VC. MAP-1, a novel proapoptotic protein containing a BH3-like motif that associates with Bax through its Bcl-2 homology domains. J Biol Chem 2001; 276: 2802-2807.
8. Voltz R, Gultekin SH, Rosenfeld MR, Gerstner E, Eichen J, Posner JB and Dalmau J. A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med 1999; 340: 1788-1795.
9. Albert ML and Darnell RB. Paraneoplastic neurological degenerations: keys to tumour immunity. Nat Rev Cancer 2004; 4: 36-44.
10. Darnell RB and Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med 2003; 349: 1543-1554.
11. Takaji M, Komatsu Y, Watakabe A, Hashikawa T and Yamamori T. Paraneoplastic antigen-like 5 gene (PNMA5) is preferentially expressed in the association areas in a primate specific manner. Cereb Cortex 2009; 19: 2865-2879.
12. Foley CJ, Freedman H, Choo SL, Onyskiw C, Fu NY, Yu VC, Tuszynski J, Pratt JC and Baksh S. Dynamics of RASSF1A/MOAP-1 association with death receptors. Mol Cell Biol 2008; 28: 4520-4535.
13. Vos MD, Dallol A, Eckfeld K, Allen NP, Donninger H, Hesson LB, Calvisi D, Latif F and Clark GJ. The RASSF1A tumor suppressor activates Bax via MOAP-1. J Biol Chem 2006; 281: 4557-4563.
14. Baksh S, Tommasi S, Fenton S, Yu VC, Martins LM, Pfeifer GP, Latif F, Downward J and Neel BG. The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death. Mol Cell 2005; 18: 637-650.
15. Chen HL and D'Mello SR. Induction of neuronal cell death by paraneoplastic Ma1 antigen. J Neurosci Res 2010; 88: 3508-3519.
16. Li J, Yang XM, Wang YH, Feng MX, Liu XJ, Zhang YL, Huang S, Wu Z, Xue F, Qin WX, Gu JR, Xia Q and Zhang ZG. Monoamine oxidase A suppresses hepatocellular carcinoma metastasis by inhibiting the adrenergic system and its transactivation of EGFR signaling. J Hepatol 2014; 60: 1225-34.
17. Dent P. Crosstalk between ERK, AKT, and cell survival. Cancer Biol Ther 2014; 15: 245-246.
18. Liu ZH, Wang MH, Ren HJ, Qu W, Sun LM, Zhang QF, Qiu XS and Wang EH. Interleukin 7 signaling prevents apoptosis by regulating bcl-2 and bax via the p53 pathway in human non-small cell lung cancer cells. Int J Clin Exp Pathol 2014; 7: 870-881.
19. Fu NY, Sukumaran SK and Yu VC. Inhibition of ubiquitin-mediated degradation of MOAP-1 by apoptotic stimuli promotes Bax function in mitochondria. Proc Natl Acad Sci U S A 2007; 104: 10051-10056.